SCHEMBL13045851

SCHEMBL13045851

COc1ccc2c(-c3ccccc3C(=O)O)c3cc/c(=[N+](/C)N)cc-3oc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 1/20 0.48
▸ USP2 O75604 2/20 0.46
▸ CFTR P13569 1/20 0.46
▸ PAX8 Q06710 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ GOPC Q9HD26 1/20 0.46
▸ CA1 P00915 5/20 0.45
▸ CA2 P00918 5/20 0.45
▸ CA12 O43570 4/20 0.45
▸ CA9 Q16790 4/20 0.45
▸ CA3 P07451 1/20 0.45
▸ CA4 P22748 1/20 0.45
▸ CA5A P35218 1/20 0.45
▸ CA7 P43166 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ CA5B Q9Y2D0 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ KDM4E B2RXH2 4/20 0.43
▸ ALDH1A1 P00352 4/20 0.43
▸ NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15355554 0.93 MEN1 (0.48) ABCB1USP2CFTRPAX8ATM
SCHEMBL20305836 0.91 ABCB1 (0.47) ABCB1USP2CFTRPAX8ATM
SCHEMBL19494880 0.87 ABCB1 (0.45) ABCB1USP2CFTRPAX8ATM
SCHEMBL10205417 0.85 USP2 (0.58) ABCB1USP2CFTRPAX8ATM
SCHEMBL20305834 0.84 P2RY6 (0.49) ABCB1USP2CFTRPAX8ATM
SCHEMBL13771828 0.83 ALDH1A1 (0.44) ABCB1USP2CFTRPAX8ATM
SCHEMBL19494844 0.80 AR (0.46) ABCB1USP2CFTRPAX8ATM
SCHEMBL19495008 0.79 ABCB1 (0.42) ABCB1USP2CFTRPAX8ATM
SCHEMBL12582030 0.79 KDM4E (0.49) ABCB1USP2CFTRPAX8ATM
SCHEMBL10082262 0.77 MEN1 (0.48) ABCB1USP2CFTRPAX8ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160356782-A1 FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS Life Technologies Corporation 2016-12-08 — — US disclosed
US-9389183-B2 Fluorogenic hydrazine-substituted compounds Life Technologies Corporation (US) 2016-07-12 — — US disclosed
US-8772487-B2 Fluorogenic hydrazine-substituted compounds Life Technologies Corporation (US) 2014-07-08 — — US disclosed
US-20130288911-A1 FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS Life Technologies Corporation 2013-10-31 — — US disclosed
US-20100291547-A1 FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS Life Technologies Corporation (US) 2010-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100291547-A1 FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS ALDH2, ALDH1A2, HLCS ABCB1 3051/4885USP2 3504/4885CFTR 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback